
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cyclin D degradation by E3 ligases in cancer progression and treatment
Shuo Qie, J. Alan Diehl
Seminars in Cancer Biology (2020) Vol. 67, pp. 159-170
Open Access | Times Cited: 51
Shuo Qie, J. Alan Diehl
Seminars in Cancer Biology (2020) Vol. 67, pp. 159-170
Open Access | Times Cited: 51
Showing 1-25 of 51 citing articles:
CRL4AMBRA1 is a master regulator of D-type cyclins
Daniele Simoneschi, Gergely Róna, Nan Zhou, et al.
Nature (2021) Vol. 592, Iss. 7856, pp. 789-793
Open Access | Times Cited: 124
Daniele Simoneschi, Gergely Róna, Nan Zhou, et al.
Nature (2021) Vol. 592, Iss. 7856, pp. 789-793
Open Access | Times Cited: 124
The AMBRA1 E3 ligase adaptor regulates the stability of cyclin D
Andrea C. Chaikovsky, Chuan Li, Edwin E. Jeng, et al.
Nature (2021) Vol. 592, Iss. 7856, pp. 794-798
Open Access | Times Cited: 115
Andrea C. Chaikovsky, Chuan Li, Edwin E. Jeng, et al.
Nature (2021) Vol. 592, Iss. 7856, pp. 794-798
Open Access | Times Cited: 115
ISG15 and ISGylation in Human Diseases
Oygul Mirzalieva, Meredith Juncker, Joshua Schwartzenburg, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 538-538
Open Access | Times Cited: 67
Oygul Mirzalieva, Meredith Juncker, Joshua Schwartzenburg, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 538-538
Open Access | Times Cited: 67
Chitosan coated copper/silver oxide nanoparticles as carriers of breast anticancer drug: Cyclin D1/P53 expressions and cytotoxicity studies
Elena Rahimi, Farzaneh Asefi, Ahmadreza Afzalinia, et al.
Inorganic Chemistry Communications (2023) Vol. 158, pp. 111581-111581
Closed Access | Times Cited: 25
Elena Rahimi, Farzaneh Asefi, Ahmadreza Afzalinia, et al.
Inorganic Chemistry Communications (2023) Vol. 158, pp. 111581-111581
Closed Access | Times Cited: 25
HDAC5 Loss Impairs RB Repression of Pro-Oncogenic Genes and Confers CDK4/6 Inhibitor Resistance in Cancer
Yingke Zhou, Xin Jin, Jian Ma, et al.
Cancer Research (2021) Vol. 81, Iss. 6, pp. 1486-1499
Open Access | Times Cited: 54
Yingke Zhou, Xin Jin, Jian Ma, et al.
Cancer Research (2021) Vol. 81, Iss. 6, pp. 1486-1499
Open Access | Times Cited: 54
USP2-Related Cellular Signaling and Consequent Pathophysiological Outcomes
Hiroshi Kitamura, Mayuko Hashimoto
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1209-1209
Open Access | Times Cited: 49
Hiroshi Kitamura, Mayuko Hashimoto
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1209-1209
Open Access | Times Cited: 49
F-Box Proteins and Cancer
Kanae Yumimoto, Yuhei Yamauchi, Keiichi I. Nakayama
Cancers (2020) Vol. 12, Iss. 5, pp. 1249-1249
Open Access | Times Cited: 46
Kanae Yumimoto, Yuhei Yamauchi, Keiichi I. Nakayama
Cancers (2020) Vol. 12, Iss. 5, pp. 1249-1249
Open Access | Times Cited: 46
Similarities and Differences of Hsp70, hsc70, Grp78 and Mortalin as Cancer Biomarkers and Drug Targets
Rajani Rai, Amy L. Kennedy, Zitha Redempta Isingizwe, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2996-2996
Open Access | Times Cited: 38
Rajani Rai, Amy L. Kennedy, Zitha Redempta Isingizwe, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2996-2996
Open Access | Times Cited: 38
E3 ligase MG53 suppresses tumor growth by degrading cyclin D1
Meng Fang, Hong-Kun Wu, Yumeng Pei, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 16
Meng Fang, Hong-Kun Wu, Yumeng Pei, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 16
PFKFB3 facilitates cell proliferation and migration in anaplastic thyroid carcinoma via the WNT/β‐catenin signaling pathway
Jinmei Deng, Yanglei Cheng, Hai Li, et al.
Endocrine (2024) Vol. 85, Iss. 2, pp. 737-750
Closed Access | Times Cited: 4
Jinmei Deng, Yanglei Cheng, Hai Li, et al.
Endocrine (2024) Vol. 85, Iss. 2, pp. 737-750
Closed Access | Times Cited: 4
F-box protein FBXO32 ubiquitinates and stabilizes D-type cyclins to drive cancer progression
Feng Li, Hongqiang Yu, Yujun Zhang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Feng Li, Hongqiang Yu, Yujun Zhang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Probiotics as Anti-Tumor Agents: Insights from Female Tumor Cell Culture Studies
Chiara Giorgi, Francesca Lombardi, Francesca Rosaria Augello, et al.
Biomolecules (2025) Vol. 15, Iss. 5, pp. 657-657
Open Access
Chiara Giorgi, Francesca Lombardi, Francesca Rosaria Augello, et al.
Biomolecules (2025) Vol. 15, Iss. 5, pp. 657-657
Open Access
Long intergenic noncoding RNA 00908 promotes proliferation and inhibits apoptosis of colorectal cancer cells by regulating KLF5 expression
Ti‐Dong Shan, Zibin Tian, Qian Li, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 2, pp. 889-899
Closed Access | Times Cited: 30
Ti‐Dong Shan, Zibin Tian, Qian Li, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 2, pp. 889-899
Closed Access | Times Cited: 30
FBXO43 increases CCND1 stability to promote hepatocellular carcinoma cell proliferation and migration
Chunming Li, Jie Zhang, Wu Wu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Chunming Li, Jie Zhang, Wu Wu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Chatterboxes: the structural and functional diversity of cyclins
Natalie J. Tatum, Jane Endicott
Seminars in Cell and Developmental Biology (2020) Vol. 107, pp. 4-20
Closed Access | Times Cited: 23
Natalie J. Tatum, Jane Endicott
Seminars in Cell and Developmental Biology (2020) Vol. 107, pp. 4-20
Closed Access | Times Cited: 23
Peptides in Colorectal Cancer: Current State of Knowledge
Sara Avilés‐Gaxiola, Erick P. Gutiérrez‐Grijalva, Josefina León‐Félix, et al.
Plant Foods for Human Nutrition (2020) Vol. 75, Iss. 4, pp. 467-476
Closed Access | Times Cited: 20
Sara Avilés‐Gaxiola, Erick P. Gutiérrez‐Grijalva, Josefina León‐Félix, et al.
Plant Foods for Human Nutrition (2020) Vol. 75, Iss. 4, pp. 467-476
Closed Access | Times Cited: 20
Proteasome regulators in pancreatic cancer
Nirosha J. Murugan, Ioannis A. Voutsadakis
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 1, pp. 38-54
Open Access | Times Cited: 12
Nirosha J. Murugan, Ioannis A. Voutsadakis
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 1, pp. 38-54
Open Access | Times Cited: 12
Methylation of KSHV vCyclin by PRMT5 contributes to cell cycle progression and cell proliferation
Danping Niu, Yuanming Ma, Pengyu Ren, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012535-e1012535
Open Access | Times Cited: 2
Danping Niu, Yuanming Ma, Pengyu Ren, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012535-e1012535
Open Access | Times Cited: 2
Xanthohumol targets the ERK1/2‑Fra1 signaling axis to reduce cyclin D1 expression and inhibit non‑small cell lung cancer
Feng Gao, Ming Li, Li Zhou, et al.
Oncology Reports (2020)
Open Access | Times Cited: 17
Feng Gao, Ming Li, Li Zhou, et al.
Oncology Reports (2020)
Open Access | Times Cited: 17
Heat Shock Protein 70 and 90 Family in Prostate Cancer
Xun Fu, Jiang Liu, Xin Yan, et al.
Life (2022) Vol. 12, Iss. 10, pp. 1489-1489
Open Access | Times Cited: 10
Xun Fu, Jiang Liu, Xin Yan, et al.
Life (2022) Vol. 12, Iss. 10, pp. 1489-1489
Open Access | Times Cited: 10
The E3 Ubiquitin Ligase Fbxo4 Functions as a Tumor Suppressor: Its Biological Importance and Therapeutic Perspectives
Shuo Qie
Cancers (2022) Vol. 14, Iss. 9, pp. 2133-2133
Open Access | Times Cited: 9
Shuo Qie
Cancers (2022) Vol. 14, Iss. 9, pp. 2133-2133
Open Access | Times Cited: 9
Targeting cyclin D1 as a therapeutic approach for papillary thyroid carcinoma
Wei Cai, Lin-Zhen Shu, Ding-Jie Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Wei Cai, Lin-Zhen Shu, Ding-Jie Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Heat shock protein family A member 8 is a prognostic marker for bladder cancer: Evidences based on experiments and machine learning
Yang Liu, Zhong-Qi Pang, Jianshe Wang, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 24, pp. 3995-4008
Open Access | Times Cited: 5
Yang Liu, Zhong-Qi Pang, Jianshe Wang, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 24, pp. 3995-4008
Open Access | Times Cited: 5
Insights into the aberrant CDK4/6 signaling pathway as a therapeutic target in tumorigenesis
Abdol-Hossein Rezaeian, Hiroyuki Inuzuka, Wenyi Wei
Advances in protein chemistry and structural biology (2022), pp. 179-201
Open Access | Times Cited: 8
Abdol-Hossein Rezaeian, Hiroyuki Inuzuka, Wenyi Wei
Advances in protein chemistry and structural biology (2022), pp. 179-201
Open Access | Times Cited: 8
Long Non-coding RNA SENP3-EIF4A1 Functions as a Sponge of miR-195-5p to Drive Triple-Negative Breast Cancer Progress by Overexpressing CCNE1
Lie Chen, Xiaofei Miao, Chenchen Si, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 11
Lie Chen, Xiaofei Miao, Chenchen Si, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 11